Discovery of innate immune receptor "brake" Siglec-E offers a novel therapeutic target to prevent organ transplant rejection ...

Ansa is accepting orders for synthetic DNA constructs ranging from 7.5 kb up to 50 kb for various applications.

Recursion said it earned its latest milestone payout by identifying differentiated, oral small molecule leads against a ...

Researchers use generative AI to design synthetic enhancers that can effectively control gene expression in healthy mammalian ...

Lipid receptor SR-B1 identified as a potential immunotherapy target to boost NK cell antitumor response in advanced ovarian ...

Researchers headed by a team at the California Institute of Technology developed an ultrasound-guided 3D printing technique ...

Zevaskyn won FDA approval upon Abeona’s second filing of a biologics license application (BLA) for the therapy.

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...

The virus likely reached humans not via bat migration but through the wildlife trade—contradicting hypotheses that it may ...

Researchers expect LICONN technology will be broadly useful to enable high-resolution tissue analysis in other organs and ...

Low blood sugar contributes to eye damage and vision loss in diabetic retinopathy; an experimental drug may help treat the ...

Careful planning can make a substantial difference on your path to commercial success. Here we delve into key considerations ...